SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost of Care for Patients in Cancer Clinical Trials
4 references·4 citing·24 second hop
Cost of Care for Patients in Cancer Clinical Trials (2000)Cost of Care for Patients in Cancer Clini…Linking Automated Databases for Research in Managed Care Settings (1997)Linking Automated Databases f…Cost of care for cancer in a health maintenance organization. (1997)Cost of care for cancer in a …Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. (1992)Overcoming the absence of soc…Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity Intervention (2019)Addressing the Financial Burd…Economic Impact of Cancer in the United States (2006)Economic Impact of Cancer in …Incremental Treatment Costs in National Cancer Institute–Sponsored Clinical Trials (2003)Incremental Treatment Costs i…Economic Analysis of Vinorelbine Plus Cisplatin Versus Paclitaxel Plus Carboplatin for Advanced Non-Small-Cell Lung Cancer (2002)Economic Analysis of Vinorelb…The logged dependent variable, heteroscedasticity, and the retransformation problem (1998)Incremental Costs of Enrolling Cancer Patients in Clinical Trials: a Population-Based Study (1999)Estimating Health Care Costs Related to Cancer Treatment From SEER-Medicare Data (2002)Economic foundations of cost-effectiveness analysis (1997)The burden of illness associated with hepatocellular carcinoma in the United States (2008)Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States (2015)Global treatment costs of breast cancer by stage: A systematic review (2018)Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues (1991)The Journal's Policy on Cost-Effectiveness Analyses (1994)The Burden of Illness of Cancer: Economic Cost and Quality of Life (2001)The friction cost method for measuring indirect costs of disease (1995)The burden of selected digestive diseases in the United States (2002)The economics of cancer care in the UK (2004)Economic Studies in Colorectal Cancer: Challenges in Measuring and Comparing Costs (2013)The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience (2013)Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer (2016)Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) (2016)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Assessment of Value of Neighborhood Socioeconomic Status in Models That Use Electronic Health Record Data to Predict Health Care Use Rates and Mortality (2020)Socioeconomic status and health: The challenge of the gradient. (1994)Measuring Social Class in US Public Health Research: Concepts, Methodologies, and Guidelines (1997)Multilevel analyses of neighbourhood socioeconomic context and health outcomes: a critical review: Table 1 (2001)
this work references cited by second hop

References

  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 1992Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology.1,655 cited
  • 1997Cost of care for cancer in a health maintenance organization.196 cited
  • 1997Linking Automated Databases for Research in Managed Care Settings166 cited

Cited by

  • 2003Incremental Treatment Costs in National Cancer Institute–Sponsored Clinical Trials79 cited
  • 2019Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity Intervention78 cited
  • 2002Economic Analysis of Vinorelbine Plus Cisplatin Versus Paclitaxel Plus Carboplatin for Advanced Non-Small-Cell Lung Cancer74 cited
  • 2006Economic Impact of Cancer in the United States73 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work